Susquehanna International Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
124,799
+54,079
| +76% | +$201K | ﹤0.01% | 4424 |
|
|
2025
Q1 | $228K | Buy |
70,720
+37,991
| +116% | +$123K | ﹤0.01% | 5380 |
|
|
2024
Q4 | $182K | Buy |
32,729
+7,956
| +32% | +$44.3K | ﹤0.01% | 5367 |
|
|
2024
Q3 | $268K | Sell |
24,773
-9,250
| -27% | -$100K | ﹤0.01% | 4438 |
|
|
2024
Q2 | $714K | Buy |
34,023
+17,431
| +105% | +$366K | ﹤0.01% | 2993 |
|
|
2024
Q1 | $529K | Sell |
16,592
-23,890
| -59% | -$761K | ﹤0.01% | 3468 |
|
|
2023
Q4 | $820K | Buy |
40,482
+20,142
| +99% | +$408K | ﹤0.01% | 3132 |
|
|
2023
Q3 | $259K | Sell |
20,340
-2,208
| -10% | -$28.1K | ﹤0.01% | 4211 |
|
|
2023
Q2 | $407K | Sell |
22,548
-56,026
| -71% | -$1.01M | ﹤0.01% | 3881 |
|
|
2023
Q1 | $1.35M | Buy |
78,574
+46,348
| +144% | +$797K | ﹤0.01% | 2473 |
|
|
2022
Q4 | $716K | Buy |
32,226
+21,668
| +205% | +$481K | ﹤0.01% | 2742 |
|
|
2022
Q3 | $85K | Buy |
10,558
+155
| +1% | +$1.25K | ﹤0.01% | 5333 |
|
|
2022
Q2 | $73K | Sell |
10,403
-9,953
| -49% | -$69.8K | ﹤0.01% | 5133 |
|
|
2022
Q1 | $308K | Sell |
20,356
-13,500
| -40% | -$204K | ﹤0.01% | 4317 |
|
|
2021
Q4 | $743K | Buy |
+33,856
| New | +$743K | ﹤0.01% | 3253 |
|